Intellia Therapeutics, Inc. company logo
Intellia Therapeutics, Inc. logo

Intellia Therapeutics, Inc. (NTLA) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$189.18M$37.57M-16.57%

Summary

Current Value
As of today, NTLA annual cash & cash equivalents is $189.18M, down -16.57% on
Historical Performance
NTLA annual cash & cash equivalents is up +53.30% over the past 3 years, and up +230.59% over the past 5 years
All-Time High Comparison
NTLA annual cash & cash equivalents is currently -63.86% below its historical high of $523.51M set on
3-Year Low Comparison
NTLA annual cash & cash equivalents is at its 3-year low
Sector Comparison
NTLA annual cash & cash equivalents is higher than 77.78% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NTLA Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$189.18M-16.6%+53.3%+230.6%+1821.6%
Quarterly Cash & Cash Equivalents$511.04M-22.4%-38.3%+25.3%
Price$11.74+20.6%-68.8%-85.9%
Annual Current Assets$639.86M-35.9%-16.8%+121.0%+6216.5%
Annual Total Liabilities$319.06M+27.2%+25.5%+395.4%+10000.0%
Annual Working Capital$529.01M-40.1%-17.8%+108.4%+6704.0%
Annual Net Income-$519.02M-7.9%-93.7%-421.5%-5341.0%

Cash and Cash Equivalents Highs

NTLA Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$523.51MN/A-63.9%
5Y$523.51M-63.9%
All$523.51M-63.9%

Cash and Cash Equivalents Lows

NTLA Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$189.18Mat low
5Y$123.41M+53.3%
All$9.85M+1821.6%

Cash and Cash Equivalents History

YearValueChange
$189.18M-16.6%
$226.75M-56.7%
$523.51M+324.2%
$123.41M-22.9%
$160.02M+179.6%
$57.23M-2.8%
YearValueChange
$58.86M-82.7%
$340.68M+24.8%
$273.06M+260.2%
$75.82M+670.1%
$9.85M-

FAQ

  • What is the current annual cash & cash equivalents of NTLA?

    As of today, NTLA annual cash & cash equivalents is $189.18M

  • What is 1-year change in NTLA annual cash & cash equivalents?

    NTLA annual cash & cash equivalents is down -16.57% year-over-year

  • What is 3-year change in NTLA annual cash & cash equivalents?

    NTLA annual cash & cash equivalents is up +53.30% over the past 3 years

  • How far is NTLA annual cash & cash equivalents from its all-time high?

    NTLA annual cash & cash equivalents is currently -63.86% below its historical high of $523.51M set on December 31, 2022

  • How does NTLA annual cash & cash equivalents rank versus sector peers?

    NTLA annual cash & cash equivalents is higher than 77.78% of companies in Healthcare sector

  • When is NTLA next annual earnings release?

    The next annual earnings release for NTLA is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. NTLA Official Website www.intelliatx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1652130/000119312525269680/0001193125-25-269680-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1652130/000095017025029007/0000950170-25-029007-index.htm
  4. NTLA Profile on Yahoo Finance finance.yahoo.com/quote/NTLA
  5. NTLA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ntla